Brief: Lumos Diagnostics And Barda To Partner To Support FebriDx Bacterial/Non-Bacterial Point-Of-Care Test

Lumos Diagnostics Holdings

03/10/2024 02:04

Oct 3 (Reuters) - Lumos Diagnostics Holdings Ltd
 LDX.AX :
    * CO AND BARDA TO PARTNER TO SUPPORT FEBRIDX
BACTERIAL/NON-BACTERIAL POINT-OF-CARE TEST
    * CO AWARDED $3 MILLION IN NON-DILUTIVE FUNDING FROM
BIOMEDICAL
ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY
    * FUNDING TO SUPPORT COMING FEBRIDX® CLIA WAIVER STUDY AND
US FDA
APPLICATION

Further company coverage:  LDX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))